[Interferon for adjuvant therapy in melanoma; although approved, not indicated].

Abstract

The Dutch melanoma group reconsidered their 1997 consensus statement on treatment of melanoma because new studies on adjuvant treatment with interferon(IFN)-alpha have been published. These have resulted in its registration for stage IIa; for stage IIb/III IFN-alpha was already registered. Overall survival should be the main endpoint of adjuvant clinical… (More)

Topics

  • Presentations referencing similar topics